🎉 M&A multiples are live!
Check it out!

InfuSystem Valuation Multiples

Discover revenue and EBITDA valuation multiples for InfuSystem and similar public comparables like Philips, Perspective Therapeutics, and Senseonics Holdings.

InfuSystem Overview

About InfuSystem

InfuSystems Holdings Inc is a health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers. INFU services are provided under a two-platform model. The first platform is Patient Services, providing the last-mile solution for clinic-to-home healthcare where the continuing treatment involves complex durable medical equipment and services. The Patient segment is comprised of Oncology, Pain Management and Wound Therapy businesses. The second platform, Device Solutions, supports the Patient Services platform and leverages strong service orientation to win incremental business from its direct payer clients. The Device segment is comprised of direct payer rentals, pump and consumable sales, and biomedical services and repair.


Founded

2005

HQ

United States of America
Employees

516

Website

infusystem.com

Financials

LTM Revenue $137M

LTM EBITDA $25.8M

EV

$144M

Valuation Multiples

Multiples.vc

Sign up to see

Valuation Multiples for 10K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

InfuSystem Financials

InfuSystem has a last 12-month revenue of $137M and a last 12-month EBITDA of $25.8M.

In the most recent fiscal year, InfuSystem achieved revenue of $135M and an EBITDA of $19.3M.

InfuSystem expects next 12-month revenue of  XXX    and NTM EBITDA of  XXX

See InfuSystem valuation multiples based on analyst estimates

InfuSystem P&L

FY 2023 FY 2024 FY 2025 LTM NTM
Revenue $126M $135M XXX XXX XXX
Gross Profit $62.6M $63.1M XXX XXX XXX
Gross Margin 50% 47% XXX XXX XXX
EBITDA $16.5M $19.3M XXX XXX XXX
EBITDA Margin 13% 14% XXX XXX XXX
Net Profit $18K $0.9M XXX XXX XXX
Net Margin 0% 1% XXX XXX XXX
Net Debt $33.0M $28.9M XXX XXX XXX

Financial data powered by Morningstar, Inc.

InfuSystem Stock Performance

As of March 14, 2025, InfuSystem's stock price is $6.

InfuSystem has current market cap of $117M, and EV of $144M.

See InfuSystem trading valuation data

InfuSystem Stock Data

EV Market Cap Price 1D Price 1M Price 3M Price 12M EPS
$144M $117M XXX XXX XXX XXX $0.13

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Sign Up

InfuSystem Valuation Multiples

As of March 14, 2025, InfuSystem has market cap of $117M and EV of $144M.

InfuSystem's trades at 1.1x LTM EV/Revenue multiple, and 5.6x LTM EBITDA.

Analysts estimate InfuSystem's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See valuation multiples for InfuSystem and 10K+ public comps

InfuSystem Financial Valuation Multiples

FY 2024 FY 2025E FY 2026E FY 2027E
EV $144M XXX XXX XXX
EV/Revenue 1.1x XXX XXX XXX
EV/EBITDA 7.5x XXX XXX XXX
P/E 49.7x XXX XXX XXX
P/E/Growth 0.7x XXX XXX XXX
EV/FCF 55.0x XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get InfuSystem Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Sign Up

InfuSystem Valuation Multiples

InfuSystem's NTM/LTM revenue growth is 9%

InfuSystem's revenue per employee for the last fiscal year averaged $0.3M, while opex per employee averaged $0.1M for the same period.

Over next 12 months, InfuSystem's ratio of sales and marketing spend to revenue is estimated to be  XXX , while its R&D spend to revenue to be  XXX .

Analysts estimate InfuSystem's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See operational valuation multiples for InfuSystem and other 10K+ public comps

InfuSystem Operational Valuation Multiples

FY 2024 NTM FY 2025E FY 2026E FY 2027E
Revenue Growth 7% XXX XXX XXX XXX
EBITDA Margin 14% XXX XXX XXX XXX
EBITDA Growth 17% XXX XXX XXX XXX
Rule of 40 (SaaS-only) 23% XXX XXX XXX XXX
Revenue per Employee $0.3M XXX XXX XXX XXX
Opex per Employee $0.1M XXX XXX XXX XXX
S&M Expenses to Revenue 8% XXX XXX XXX XXX
G&A Expenses to Revenue 38% XXX XXX XXX XXX
R&D Expenses to Revenue n/a XXX XXX XXX XXX
Opex to Revenue 47% XXX XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics
Pharma Analytics
Private Equity
ERP Software
Developer Tools
Consumer SaaS
Streaming Platforms

InfuSystem Public Comps

See public comps and valuation multiples for Medical Devices comps
EV/Revenue EV/EBITDA
2025E 2026E 2027E 2025E 2026E 2027E
Philips XXX XXX XXX XXX XXX XXX
Perspective Therapeutics XXX XXX XXX XXX XXX XXX
SmartVest XXX XXX XXX XXX XXX XXX
Myomo XXX XXX XXX XXX XXX XXX
Senseonics Holdings XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX

Valuation data powered by FactSet, Inc.

InfuSystem M&A and Investment Activity

InfuSystem acquired  XXX companies to date.

Last acquisition by InfuSystem was  XXXXXXXX, XXXXX XXXXX XXXXXX . InfuSystem acquired  XXXXXXXX for  XXX (EV/Revenue multiple of  XXX ).

See M&A valuation multiples

Latest Acquisitions by InfuSystem

Acquired Company EV EV/Revenue EV/EBITDA
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.

Sign Up

About InfuSystem

When was InfuSystem founded? InfuSystem was founded in 2005.
Where is InfuSystem headquartered? InfuSystem is headquartered in United States of America.
How many employees does InfuSystem have? As of today, InfuSystem has 516 employees.
Who is the CEO of InfuSystem? InfuSystem's CEO is Mr. Richard DiIorio.
Is InfuSystem publicy listed? Yes, InfuSystem is a public company listed on ASE.
What is the stock symbol of InfuSystem? InfuSystem trades under INFU ticker.
When did InfuSystem go public? InfuSystem went public in 1992.
Who are competitors of InfuSystem? Similar companies to InfuSystem include e.g. Philips, Perspective Therapeutics, SmartVest, Myomo.
What is the current market cap of InfuSystem? InfuSystem's current market cap is $117M
What is the current revenue of InfuSystem? InfuSystem's last 12-month revenue is $137M.
What is the current EBITDA of InfuSystem? InfuSystem's last 12-month EBITDA is $25.8M.
What is the current EV/Revenue multiple of InfuSystem? Current revenue multiple of InfuSystem is 1.1x.
What is the current EV/EBITDA multiple of InfuSystem? Current EBITDA multiple of InfuSystem is 5.6x.
What is the current revenue growth of InfuSystem? InfuSystem revenue growth between 2023 and 2024 was 7%.
Is InfuSystem profitable? Yes, InfuSystem is EBITDA-positive (as of the last 12 months).

Join Now Or Talk To Us

Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.